Niemeyer Hultstrand J

No ORCID on file · 1 paper in corpus · active 2022
2022
The Lancet regional health. Europe ·doi:10.1016/j.lanepe.2022.100470

BackgroundEvidence on a possible association between newer hormonal contraceptives (HC) and risk of breast cancer remains inconclusive, especially as concerns progestogen-only methods.MethodsIn this nationwide prospective cohort study, all …